BiPAP

Philips Respironics was ordered by the U.S. FDA to notify patients and others of a 2021 recall of some breathing assistance machines.

A recent inspection by the FDA at one of Philips' manufacturing facilities is raising new questions about its handling of the safety problems.

New Concerns After FDA Investigates Philips CPAP Recall. A recent inspection by the FDA at one of Philips' manufacturing facilities is raising new ...

... the U.S. Food and Drug Administration (FDA) alerted the public about a voluntary recall of specific Philips Respironics ventilators, BiPAP, and CPAP ...

TORONTO -- Health Canada has posted a recall alert from Philips ... Pressure (BIPAP), and Mechanical Ventilators,” according to the statement.

In its recall announcement, Philips said the foam used in its machines for noise reduction can break down and be ingested by users, causing serious ...

The lawsuit, filed by the Beasley Allen law firm, alleges that Philips Respironics continued to market and sell the defectively designed breathing devices despite knowing about the devices’ potential to cause serious and life-threatening injuries and failed to warn consumers of the serious health risks the devices posed.  On April 26, 2021, Philips made an initial disclosure that it had received several consumer complaints about the presence of black debris within the device’s air pathway and reports of headache, upper airway irritation, cough, chest pressure, and …

In June 2021, Philips recalled millions of its CPAP and BiPAP machines as well as several ventilator devices that were manufactured between 2009 and April 26, 2021.  The recall was caused by potential health risks associated with exposure to the degraded sound abatement foam particles and chemical emissions from the foam material.  The Philips BiPAP and CPAP machines and ventilators that are affected by the recall include:  E30 (Emergency Use Authorization) DreamStation ASV DreamStation ST, AVAPS SystemOne ASV4 C Series ASV, S/T, AVAPS OmniLab Advanced Plus In-Lab Titration Device SystemOne (Q series) DreamStation CPAP, Auto CPAP, BiPAP DreamStation GO CPAP, …

The FDA is alerting consumers that Philips Respironics has recalled millions of BiPAP and CPAP machines due to potential health risks.    The concern is polyester-based polyurethane (PE-PUR) sound abatement foam, which is used to mitigate vibration and sound.  According to the manufacturer, the foam may break down and potentially enter the device’s air pathway, releasing debris that may be inhaled or swallowed by the device’s user.    The affected machines were manufactured between 2009 and April 26, 2021.  For more information, see Philips’ Respironics recall notification. …

A lawsuit recently filed in federal court in Georgia outlines the claims of a Florida man who used a Philips-manufactured CPAP machine for more than five years, closely following all operational instructions. Diagnosed with lung cancer in June 2021, he has also suffered damage to his respiratory system, cellular damage and DNA damage, among other effects. Read the lawsuit here. …